Protocol for the cost-effectiveness of parenteral iron and oral iron therapy for first-line management of anaemia among pregnant women in a natural programme setting in Gujarat. Issue 6 (30th June 2021)

• Record Type: Journal Article
• Authors: Saha, Somen; Desai, Bharat; Fancy, Manish; Puwar, Tapasvi; Saxena, Deepak; Shah, Komal; Pandya, Apurvakumar
• Is Part Of: BMJ open. Volume 11:Issue 6(2021)
• Publication Date: 2021-06-30
• Subjects: anaemia -- health economics -- maternal medicine -- public health -- protocols & guidelines; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2020-044712
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Introduction: Maternal anaemia is a major public health issue in India. The government of India recommends parenteral iron to manage moderate and severe grades of anaemia. In contrast to its clinical efficacy, the cost-effectiveness of intravenous iron sucrose and ferric carboxymaltose is not yet established in Indian context. This article illustrates the protocol of health technology assessment to evaluate the cost-effectiveness of intravenous therapy on the improvement of haemoglobin concentration over oral therapy. Methods and analysis: The study will be carried out in two districts of Gujarat state. The study participants will be selected by a proportionate sampling method from the rural, tribal, desert and coastal region of the districts. Data will be collected over 1 year on key outcome indicators using a mixed-method approach. Key informant interviews will be conducted, and cost data will be gathered to perform cost-effectiveness analysis. Ethics and dissemination: This study is approved by the Technical Appraisal Committee of Health Technology Assessment India, Department of Health Research and Institutional Ethics Committee of the Indian Institute of Public Health, Gandhinagar.